372 related articles for article (PubMed ID: 32999024)
41. Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.
Schiffner T; de Val N; Russell RA; de Taeye SW; de la Peña AT; Ozorowski G; Kim HJ; Nieusma T; Brod F; Cupo A; Sanders RW; Moore JP; Ward AB; Sattentau QJ
J Virol; 2016 Jan; 90(2):813-28. PubMed ID: 26512083
[TBL] [Abstract][Full Text] [Related]
42. Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits.
Yang YR; McCoy LE; van Gils MJ; Andrabi R; Turner HL; Yuan M; Cottrell CA; Ozorowski G; Voss J; Pauthner M; Polveroni TM; Messmer T; Wilson IA; Sanders RW; Burton DR; Ward AB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941772
[TBL] [Abstract][Full Text] [Related]
43. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.
Kulp DW; Steichen JM; Pauthner M; Hu X; Schiffner T; Liguori A; Cottrell CA; Havenar-Daughton C; Ozorowski G; Georgeson E; Kalyuzhniy O; Willis JR; Kubitz M; Adachi Y; Reiss SM; Shin M; de Val N; Ward AB; Crotty S; Burton DR; Schief WR
Nat Commun; 2017 Nov; 8(1):1655. PubMed ID: 29162799
[TBL] [Abstract][Full Text] [Related]
44. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers.
de Taeye SW; de la Peña AT; Vecchione A; Scutigliani E; Sliepen K; Burger JA; van der Woude P; Schorcht A; Schermer EE; van Gils MJ; LaBranche CC; Montefiori DC; Wilson IA; Moore JP; Ward AB; Sanders RW
J Biol Chem; 2018 Feb; 293(5):1688-1701. PubMed ID: 29222332
[TBL] [Abstract][Full Text] [Related]
45. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
[TBL] [Abstract][Full Text] [Related]
46. Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies.
Torrents de la Peña A; Sanders RW
Retrovirology; 2018 Sep; 15(1):63. PubMed ID: 30208933
[TBL] [Abstract][Full Text] [Related]
47. Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.
Leaman DP; Stano A; Chen Y; Zhang L; Zwick MB
J Virol; 2021 Jun; 95(13):e0000521. PubMed ID: 33883221
[TBL] [Abstract][Full Text] [Related]
48. Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.
Chung NP; Matthews K; Kim HJ; Ketas TJ; Golabek M; de Los Reyes K; Korzun J; Yasmeen A; Sanders RW; Klasse PJ; Wilson IA; Ward AB; Marozsan AJ; Moore JP; Cupo A
Retrovirology; 2014 Apr; 11():33. PubMed ID: 24767177
[TBL] [Abstract][Full Text] [Related]
49. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.
Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK
J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064
[TBL] [Abstract][Full Text] [Related]
50. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.
Davis-Gardner ME; Alfant B; Weber JA; Gardner MR; Farzan M
mBio; 2020 Jan; 11(1):. PubMed ID: 31937648
[TBL] [Abstract][Full Text] [Related]
51. Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers.
Sliepen K; Medina-Ramírez M; Yasmeen A; Moore JP; Klasse PJ; Sanders RW
Virology; 2015 Dec; 486():116-20. PubMed ID: 26433050
[TBL] [Abstract][Full Text] [Related]
52. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
Bibollet-Ruche F; Russell RM; Ding W; Liu W; Li Y; Wagh K; Wrapp D; Habib R; Skelly AN; Roark RS; Sherrill-Mix S; Wang S; Rando J; Lindemuth E; Cruickshank K; Park Y; Baum R; Carey JW; Connell AJ; Li H; Giorgi EE; Song GS; Ding S; Finzi A; Newman A; Hernandez GE; Machiele E; Cain DW; Mansouri K; Lewis MG; Montefiori DC; Wiehe KJ; Alam SM; Teng IT; Kwong PD; Andrabi R; Verkoczy L; Burton DR; Korber BT; Saunders KO; Haynes BF; Edwards RJ; Shaw GM; Hahn BH
mBio; 2023 Feb; 14(1):e0337022. PubMed ID: 36629414
[TBL] [Abstract][Full Text] [Related]
53. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.
Whitaker N; Hickey JM; Kaur K; Xiong J; Sawant N; Cupo A; Lee WH; Ozorowski G; Medina-Ramírez M; Ward AB; Sanders RW; Moore JP; Joshi SB; Volkin DB; Dey AK
J Pharm Sci; 2019 Jul; 108(7):2264-2277. PubMed ID: 30776383
[TBL] [Abstract][Full Text] [Related]
54. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
[TBL] [Abstract][Full Text] [Related]
55. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
56. Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle.
Brouwer PJM; Antanasijevic A; Berndsen Z; Yasmeen A; Fiala B; Bijl TPL; Bontjer I; Bale JB; Sheffler W; Allen JD; Schorcht A; Burger JA; Camacho M; Ellis D; Cottrell CA; Behrens AJ; Catalano M; Del Moral-Sánchez I; Ketas TJ; LaBranche C; van Gils MJ; Sliepen K; Stewart LJ; Crispin M; Montefiori DC; Baker D; Moore JP; Klasse PJ; Ward AB; King NP; Sanders RW
Nat Commun; 2019 Sep; 10(1):4272. PubMed ID: 31537780
[TBL] [Abstract][Full Text] [Related]
57. Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.
Martin F; Marcelino JM; Palladino C; Bártolo I; Tracana S; Moranguinho I; Gonçalves P; Mateus R; Calado R; Borrego P; Leitner T; Clemente S; Taveira N
Microbiol Spectr; 2022 Dec; 10(6):e0163422. PubMed ID: 36445130
[TBL] [Abstract][Full Text] [Related]
58. Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.
Torrents de la Peña A; Julien JP; de Taeye SW; Garces F; Guttman M; Ozorowski G; Pritchard LK; Behrens AJ; Go EP; Burger JA; Schermer EE; Sliepen K; Ketas TJ; Pugach P; Yasmeen A; Cottrell CA; Torres JL; Vavourakis CD; van Gils MJ; LaBranche C; Montefiori DC; Desaire H; Crispin M; Klasse PJ; Lee KK; Moore JP; Ward AB; Wilson IA; Sanders RW
Cell Rep; 2017 Aug; 20(8):1805-1817. PubMed ID: 28834745
[TBL] [Abstract][Full Text] [Related]
59. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
60. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.
Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL
Front Immunol; 2020; 11():984. PubMed ID: 32582155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
